Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia. [electronic resource]
Producer: 20140218Description: 1606-11 p. digitalISSN:- 1873-5835
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- genetics
- Bone Marrow -- pathology
- Cytogenetic Analysis
- Female
- Flow Cytometry
- Humans
- Induction Chemotherapy
- Leukemia, Myeloid, Acute -- diagnosis
- Male
- Middle Aged
- Neoplasm Staging
- Neoplasm, Residual
- Treatment Outcome
- WT1 Proteins -- genetics
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.